Ra Capital Management as of March 31, 2025
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 85 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s - SH (ASND) | 26.8 | $1.6B | 10M | 155.86 | |
| Vaxcyte SH (PCVX) | 7.7 | $460M | 12M | 37.76 | |
| Rhythm Pharmaceuticals SH (RYTM) | 5.4 | $322M | 6.1M | 52.97 | |
| Janux Therapeutics SH (JANX) | 5.0 | $302M | 11M | 27.00 | |
| Newamsterdam Pharma Co Nv SH (NAMS) | 3.5 | $208M | 10M | 20.47 | |
| Arcellx SH (ACLX) | 3.3 | $199M | 3.0M | 65.60 | |
| Edgewise Therapeutics SH (EWTX) | 3.3 | $196M | 8.9M | 22.00 | |
| Avidity Biosciences SH (RNA) | 3.1 | $186M | 6.3M | 29.52 | |
| Wave Life Sciences SH (WVE) | 2.5 | $147M | 18M | 8.08 | |
| 89bio SH (ETNB) | 2.4 | $145M | 20M | 7.27 | |
| Ars Pharmaceuticals SH (SPRY) | 2.3 | $137M | 11M | 12.58 | |
| Sionna Therapeutics SH (SION) | 1.8 | $109M | 10M | 10.46 | |
| Lenz Therapeutics SH (LENZ) | 1.8 | $107M | 4.2M | 25.71 | |
| Dyne Therapeutics SH (DYN) | 1.7 | $102M | 9.7M | 10.46 | |
| Tyra Biosciences SH (TYRA) | 1.7 | $99M | 11M | 9.30 | |
| Mineralys Therapeutics SH (MLYS) | 1.6 | $98M | 6.1M | 15.88 | |
| Geron Corp SH (GERN) | 1.6 | $96M | 60M | 1.59 | |
| Rxsight SH (RXST) | 1.6 | $95M | 3.7M | 25.25 | |
| Bicara Therapeutics SH (BCAX) | 1.5 | $91M | 7.0M | 13.03 | |
| Disc Medicine SH (IRON) | 1.3 | $78M | 1.6M | 49.64 | |
| Gh Research SH (GHRS) | 1.3 | $77M | 6.9M | 11.03 | |
| Apogee Therapeutics SH (APGE) | 1.0 | $59M | 1.6M | 37.36 | |
| Dianthus Therapeutics SH (DNTH) | 0.9 | $52M | 2.9M | 18.14 | |
| Zai Lab Ltd- SH (ZLAB) | 0.8 | $47M | 1.3M | 36.14 | |
| Day One Biopharmaceuticals I SH (DAWN) | 0.8 | $46M | 5.8M | 7.93 | |
| Septerna SH (SEPN) | 0.7 | $41M | 7.0M | 5.79 | |
| Tourmaline Bio SH (TRML) | 0.6 | $39M | 2.5M | 15.21 | |
| Climb Bio SH (CLYM) | 0.6 | $38M | 31M | 1.22 | |
| Scholar Rock Holding Corp SH (SRRK) | 0.6 | $37M | 1.1M | 32.15 | |
| Urogen Pharma SH (URGN) | 0.6 | $36M | 3.2M | 11.06 | |
| Artiva Biotherapeutics SH (ARTV) | 0.5 | $30M | 9.9M | 3.00 | |
| Fulcrum Therapeutics SH (FULC) | 0.5 | $30M | 10M | 2.88 | |
| Vor Biopharma SH (VOR) | 0.5 | $28M | 40M | 0.72 | |
| Astria Therapeutics SH (ATXS) | 0.5 | $27M | 5.1M | 5.34 | |
| Kura Oncology SH (KURA) | 0.4 | $26M | 4.0M | 6.60 | |
| Structure Therapeutics SH (GPCR) | 0.4 | $26M | 1.5M | 17.31 | |
| Cidara Therapeutics SH (CDTX) | 0.4 | $24M | 1.1M | 21.54 | |
| Aerovate Therapeutics SH (AVTE) | 0.4 | $23M | 9.2M | 2.51 | |
| Ideaya Biosciences SH (IDYA) | 0.4 | $22M | 1.3M | 16.38 | |
| Iteos Therapeutics SH | 0.4 | $22M | 3.6M | 5.97 | |
| Travere Therapeutics SH (TVTX) | 0.3 | $21M | 1.2M | 17.92 | |
| Nkarta SH (NKTX) | 0.3 | $20M | 11M | 1.84 | |
| Glaukos Corp SH (GKOS) | 0.3 | $19M | 190k | 98.42 | |
| Monopar Therapeutics SH (MNPR) | 0.3 | $19M | 511k | 36.41 | |
| Metsera SH (MTSR) | 0.3 | $18M | 676k | 27.22 | |
| Eyepoint Pharmaceuticals SH (EYPT) | 0.3 | $17M | 3.2M | 5.42 | |
| 10x Genomics Inc-class A SH (TXG) | 0.3 | $17M | 1.9M | 8.73 | |
| Acrivon Therapeutics SH (ACRV) | 0.3 | $17M | 8.3M | 2.03 | |
| Enliven Therapeutics SH (ELVN) | 0.3 | $17M | 849k | 19.68 | |
| Acumen Pharmaceuticals SH (ABOS) | 0.3 | $16M | 15M | 1.10 | |
| Solid Biosciences SH (SLDB) | 0.3 | $16M | 4.3M | 3.70 | |
| Ceribell SH (CBLL) | 0.3 | $16M | 825k | 19.21 | |
| Nurix Therapeutics SH (NRIX) | 0.3 | $16M | 1.3M | 11.88 | |
| Insmed SH (INSM) | 0.3 | $15M | 200k | 76.29 | |
| Taysha Gene Therapies SH (TSHA) | 0.3 | $15M | 11M | 1.39 | |
| Pepgen SH (PEPG) | 0.3 | $15M | 11M | 1.41 | |
| 4d Molecular Therapeutics In SH (FDMT) | 0.2 | $15M | 4.6M | 3.23 | |
| Protara Therapeutic SH (TARA) | 0.2 | $15M | 3.4M | 4.26 | |
| Larimar Therapeutics SH (LRMR) | 0.2 | $13M | 6.0M | 2.15 | |
| Eledon Pharmaceuticals SH (ELDN) | 0.2 | $12M | 3.6M | 3.39 | |
| Alector SH (ALEC) | 0.2 | $12M | 9.7M | 1.23 | |
| Sera Prognostics Inc-a SH (SERA) | 0.2 | $11M | 3.0M | 3.68 | |
| Mbx Biosciences SH (MBX) | 0.2 | $11M | 1.5M | 7.38 | |
| Bicycle Therapeutics Plc- SH (BCYC) | 0.2 | $9.3M | 1.1M | 8.49 | |
| Arcus Biosciences SH (RCUS) | 0.1 | $8.9M | 1.1M | 7.85 | |
| Surrozen SH (SRZN) | 0.1 | $7.9M | 679k | 11.66 | |
| Immatics Nv SH (IMTX) | 0.1 | $7.9M | 1.8M | 4.51 | |
| Avalo Therapeutics SH (AVTX) | 0.1 | $7.7M | 967k | 8.01 | |
| Perceptive Capital Solutions SH (PCSC) | 0.1 | $7.7M | 750k | 10.30 | |
| Bright Minds Biosciences SH (DRUG) | 0.1 | $7.4M | 206k | 36.07 | |
| Aclaris Therapeutics SH (ACRS) | 0.1 | $7.1M | 4.7M | 1.53 | |
| Acadia Healthcare SH (ACHC) | 0.1 | $6.6M | 217k | 30.32 | |
| Beta Bionics SH (BBNX) | 0.1 | $6.1M | 500k | 12.24 | |
| Xencor SH (XNCR) | 0.1 | $6.1M | 575k | 10.64 | |
| Werewolf Therapeutics SH (HOWL) | 0.1 | $6.0M | 6.1M | 0.97 | |
| Adicet Bio SH (ACET) | 0.1 | $5.7M | 7.5M | 0.76 | |
| Humacyte SH (HUMA) | 0.1 | $5.6M | 3.3M | 1.71 | |
| Zura Bio SH (ZURA) | 0.1 | $4.2M | 3.2M | 1.29 | |
| Bioage Labs SH (BIOA) | 0.1 | $4.0M | 1.1M | 3.76 | |
| Boundless Bio SH (BOLD) | 0.1 | $3.3M | 2.2M | 1.51 | |
| Newamsterdam Pharma Co Nv-27 SH (NAMSW) | 0.1 | $3.0M | 333k | 8.99 | |
| Sutro Biopharma SH (STRO) | 0.0 | $2.9M | 4.4M | 0.65 | |
| Lexeo Therapeutics SH (LXEO) | 0.0 | $1.9M | 547k | 3.47 | |
| Cytomx Therapeutics SH (CTMX) | 0.0 | $636k | 1.0M | 0.64 | |
| Scilex Holding SH | 0.0 | $258k | 1.0M | 0.25 |
